Recombinant MAPT (Tilavonemab Biosimilar) antibody

Catalog No. ABIN7598041

The Chimeric Chimeric anti-MAPT (Tilavonemab Biosimilar) antibody has been validated for . It is suitable to detect MAPT (Tilavonemab Biosimilar) in samples from Human.

Quick Overview for Recombinant MAPT (Tilavonemab Biosimilar) antibody (ABIN7598041)

Target: MAPT (Tilavonemab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Chimeric

Clonality: Chimeric

Conjugate: This MAPT (Tilavonemab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-MAPT (Tilavonemab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Tilavonemab Biosimilar Antibody

Specificity: MAPTL, Paired helical filament-tau, MTBT1, Microtubule-associated protein tau, TAU, Neurofibrillary tangle protein, MAPT, PHF-tau

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG4 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1.24 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for MAPT (Tilavonemab Biosimilar)

Target: MAPT (Tilavonemab Biosimilar)

Alternative Name: Tilavonemab Biosimilar

Target Type: Biosimilar

Background: MAPTL, Paired helical filament-tau, MTBT1, Microtubule-associated protein tau, TAU, Neurofibrillary tangle protein, MAPT, PHF-tau

UniProt: P10636

CAS-No: 2096513-89-0